Medical Xpress - Cardiology

FEBRUARY 14, 2025

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.

Heart Attack 139

Heart Attack Heart attacks Research Kidney Disease 139

Med Page Today

FEBRUARY 14, 2025

(MedPage Today) -- The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk patients with type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular risk factors, a prespecified.

Kidney Disease 83

Kidney Disease Heart Attack Heart attacks Diabetes 83

Science Daily - Heart Disease

FEBRUARY 14, 2025

New research shows sotagliflozin is the only drug in its class to demonstrate these results.

Heart Attack 114

Heart Attack Heart attacks Kidney Disease Heart Failure 114

MIBHS

FEBRUARY 15, 2025

Secondary hypertension : This type results from an underlying condition such as kidney disease, hormonal disorders, or the use of certain medications. The Link Between High Blood Pressure and Heart Health Your heart and blood vessels form a complex network that ensures oxygen and nutrients reach every part of your body.

Blood Pressure 52

Blood Pressure Hypertension Chest Pain ACE Inhibitor 52

DAIC

JANUARY 19, 2024

This leaves a gap in the care of these patients and increases their risk for heart attack, stroke and heart failure progression. HTN accelerates the progression of atherosclerosis and leads to increased risk of major cardiac events like heart attack, heart failure, kidney disease and other end organ damage.

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

DAIC

APRIL 7, 2024

High blood pressure, or hypertension , is a leading cause of heart attacks, strokes and death. It occurs when the heart has to work harder to push blood through the blood vessels, increasing pressure inside the vessels. Centers for Disease Control and Prevention (CDC) estimates that nearly half of U.S.

Blood Pressure 111

Blood Pressure Heart Attack Heart attacks Hypertension 111

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111